富瑞集团维持买入评级，上调目标价至美元

JefferiesanalystAmyLimaintains$Biohaven(BHVN.US)$withabuyrating,andadjuststhetargetpricefrom$57to$64.

AccordingtoTipRanksdata,theanalysthasasuccessrateof33.3%andatotalaveragereturnof-35.2%overthepastyear.

Note:

TipRanks,anindependentthirdparty,providesanalysisdatafromfinancialanalystsandcalculatestheAverageReturnsandSuccessRatesoftheanalysts'recommendations.Theinformationpresentedisnotaninvestmentrecommendationandisintendedforinformationalpurposesonly.

Successrateisthenumberoftheanalyst'ssuccessfulratings,dividedbyhis/hertotalnumberofratingsoverthepastyear.AsuccessfulratingisonebasedonifTipRanks'virtualportfolioearnedapositivereturnfromthestock.TotalaveragereturnistheaveragerateofreturnthattheTipRanks'virtualportfoliohasearnedoverthepastyear.Theseportfoliosareestablishedbasedontheanalyst'spreliminaryratingandareadjustedaccordingtothechangesintherating.

TipRanksprovidesarankingofeachanalystupto5stars,whichisrepresentativeofallrecommendationsfromtheanalyst.Ananalyst'spastperformanceisevaluatedonascaleof1to5stars,withmorestarsindicatingbetterperformance.Thestarlevelisdeterminedbyhis/hertotalsuccessrateandaveragereturn.